Androgen insensitivity syndrome screening: Difference between revisions
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
==Screening== | ==Screening== | ||
* The diagnosis of AIS is mostly made postnatally. But, in a study which diagnosed mid-second trimester fetus with thick nuchal translucency (NT) / nuchal fold (NF) and short limbs was likely to be AIS. Hence, appearance of fetal sex on ultrasound should be compared with genetic sex. <ref name="pmid17605153">{{cite journal |vauthors=Yalinkaya A, Yayla M, Erdemoglu M |title=Prenatal diagnosis of a fetus with androgen insensitivity syndrome (AIS) |journal=Prenat. Diagn. |volume=27 |issue=9 |pages=856–7 |year=2007 |pmid=17605153 |doi=10.1002/pd.1747 |url=}}</ref> | * The diagnosis of AIS is mostly made postnatally. But, in a study which diagnosed mid-second trimester fetus with thick nuchal translucency (NT) / nuchal fold (NF) and short limbs was likely to be AIS. Hence, appearance of fetal sex on ultrasound should be compared with genetic sex. <ref name="pmid17605153">{{cite journal |vauthors=Yalinkaya A, Yayla M, Erdemoglu M |title=Prenatal diagnosis of a fetus with androgen insensitivity syndrome (AIS) |journal=Prenat. Diagn. |volume=27 |issue=9 |pages=856–7 |year=2007 |pmid=17605153 |doi=10.1002/pd.1747 |url=}}</ref> | ||
*With increased use, discordance among prenatal testing modalities such as preimplantation genetic screening, noninvasive prenatal screening, and ultrasonography will become more common requiring expert navigation to identify true pathology. <ref name="pmid25569013">{{cite journal| author=Franasiak JM, Yao X, Ashkinadze E, Rosen T, Scott RT| title=Discordant embryonic aneuploidy testing and prenatal ultrasonography prompting androgen insensitivity syndrome diagnosis. | journal=Obstet Gynecol | year= 2015 | volume= 125 | issue= 2 | pages= 383-6 | pmid=25569013 | doi=10.1097/AOG.0000000000000503 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25569013 }} </ref> | |||
==References== | ==References== | ||
Revision as of 12:10, 13 July 2017
|
Androgen insensitivity syndrome Microchapters |
|
Differentiating Androgen insensitivity syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Androgen insensitivity syndrome screening On the Web |
|
American Roentgen Ray Society Images of Androgen insensitivity syndrome screening |
|
Directions to Hospitals Treating Androgen insensitivity syndrome |
|
Risk calculators and risk factors for Androgen insensitivity syndrome screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The diagnosis of AIS is mostly made postnatally. Studies have shown that the AIS may be identified prenatally by imaging techniques and comparative study.
Screening
- The diagnosis of AIS is mostly made postnatally. But, in a study which diagnosed mid-second trimester fetus with thick nuchal translucency (NT) / nuchal fold (NF) and short limbs was likely to be AIS. Hence, appearance of fetal sex on ultrasound should be compared with genetic sex. [1]
- With increased use, discordance among prenatal testing modalities such as preimplantation genetic screening, noninvasive prenatal screening, and ultrasonography will become more common requiring expert navigation to identify true pathology. [2]
References
- ↑ Yalinkaya A, Yayla M, Erdemoglu M (2007). "Prenatal diagnosis of a fetus with androgen insensitivity syndrome (AIS)". Prenat. Diagn. 27 (9): 856–7. doi:10.1002/pd.1747. PMID 17605153.
- ↑ Franasiak JM, Yao X, Ashkinadze E, Rosen T, Scott RT (2015). "Discordant embryonic aneuploidy testing and prenatal ultrasonography prompting androgen insensitivity syndrome diagnosis". Obstet Gynecol. 125 (2): 383–6. doi:10.1097/AOG.0000000000000503. PMID 25569013.